论文部分内容阅读
应用辨证施治配合放射治疗华侨港澳鼻咽癌患者231例,治后三、五年生存率及转移率;Ⅰ期为100％、80％及○;Ⅱ期为73％、57.8％及6.7％;Ⅲ期为54.8％、33.3％及21.4％;Ⅳ期为25.8％、18.6％及40.2％。按中医分型则肺胃阴伤型为73.5％、50.5％及10.9％;脾胃湿困型为29.7％、21.6％及51.4％;血淤型为25.8％、18.3％及32.3％。华侨港澳鼻咽癌患者五年生存率为32.9％,低于国内患者68.18％(P<0.005)。
Application of Syndrome Differentiation and Radiotherapy for 231 cases of Huaqiao, Hong Kong, and Australian nasopharyngeal carcinoma patients, survival rate and metastasis rate after 3 and 5 years after treatment; Phase I is 100%, 80% and ○; Phase II is 73%, 57.8% and 6.7% Phase III was 54.8%, 33.3% and 21.4%; Phase IV was 25.8%, 18.6% and 40.2%. According to the classification of Chinese medicine, the types of lung-stomach injuries were 73.5%, 50.5%, and 10.9%; the spleen-stomach wet-sleepy types were 29.7%, 21.6%, and 51.4%; and the blood-staining types were 25.8%, 18.3%, and 32.3%. The five-year survival rate of NPC patients with nasopharyngeal carcinoma was 32.9%, which was lower than 68.18% of domestic patients (P<0.005).